Education
About Us
Working with TipRanks
Follow Us
Claude Maraoui Insider Profile
11 Followers
Claude Maraoui, President & CEO, Director at Journey Medical Corp, holds 2.05M shares in Journey Medical Corp (Ticker: DERM). Most recently, Claude Maraoui Sold $40,456 shares of Journey Medical Corp on Mar 10, 2025 for an estimated value of 203.45K.
Claude Maraoui Journey Medical Corp (DERM)President & CEO, Director
Journey Medical Corp (DERM)
President & CEO, Director
Ranked #81,914 out of 100,956 Corporate Insiders
Profitable Transactions
3 out of 5 Profitable Transactions
Average Return
-23.20%
Average return per transaction
Time Frame
Compare to
Insider Roles
President & CEO, Director
Roles that Claude Maraoui holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 25, 2024 - Mar 25, 2025
Return:+79.10%
The most profitable trade made by Claude Maraoui
Claude Maraoui's Trading History
List of latest transactions for each holding click on a transaction to see Claude Maraoui's performance on stock
You May Also Like
Claude Maraoui insider profile FAQ
What is the percentage of profitable transactions made by Claude Maraoui?
The percentage of profitable transactions made by Claude Maraoui is 60%.
What is the average return per transaction made by Claude Maraoui?
The average return per transaction made by Claude Maraoui is -23.20%.
What stocks does Claude Maraoui hold?
Claude Maraoui holds: DERM stocks.
What was Claude Maraoui’s latest transaction?
Claude Maraoui latest transaction was an Informative Sell of $203.45K.
What was Claude Maraoui's most profitable transaction?
Claude Maraoui’s most profitable transaction was an Informative Buy of DERM stock on March 25, 2024. The return on the trade was 79.10%.
What is Claude Maraoui's role in Journey Medical Corp?
Claude Maraoui's role in Journey Medical Corp is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.